Ischaemic heart disease in the ageing woman

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 27, Issue 5, 2013, Pages 689-697

  Papadopoulou, Sofia A ^a   Kaski, Juan Carlos ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

chest pain; ischaemic heart disease; women

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; MEDROXYPROGESTERONE ACETATE; PLACEBO;

AGING; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CORONARY ARTERY CALCIUM SCORE; EXERCISE TEST; EXERCISE TOLERANCE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL SERVICE; MENOPAUSE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK FACTOR; SYNDROME X; THORAX PAIN; WOMEN'S HEALTH;

CHEST PAIN; ISCHAEMIC HEART DISEASE; WOMEN;

AGING; CORONARY ANGIOGRAPHY; DELAYED DIAGNOSIS; EXERCISE TEST; FEMALE; HUMANS; MENOPAUSE; MICROVASCULAR ANGINA; MYOCARDIAL ISCHEMIA; PRIMARY PREVENTION; RISK FACTORS; SEX FACTORS;

EID: 84883897394     PISSN: 15216934     EISSN: 15321932     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2013.03.003     Document Type: Article

References (49)

1. G. Ciambrone, and J.C. Kaski The importance of gender differences in the diagnosis and management of cardiovascular disease Curr Pharm Des 17 2011 1079 1081
2. L. Mosca, E.J. Benjamin, and K. Berra Effectiveness-based guidelines for the prevention of cardiovascular disease in women, 2011 update: a guideline from the American Heart Association Circulation 123 2011 1243 1262
3. M. Gulati, L.J. Shaw, and C.N. Bairey Merz Myocardial ischemia in women: lessons from the NHLBI WISE study Clin Cardiol 35 2012 141 148
4. C.N. Bairey Merz, L.J. Shaw, and S.E. Reis Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease J Am Coll Cardiol 47 3 Suppl 2006 S21 S29
5. T.A. Manolio, T.A. Pearson, and N.K. Wenger Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop Ann Epidemiol 2 1992 161 176
6. N. Johnston, K. Schenck-Gustafsson, and B. Lagerqvist Are we using cardiovascular medications and coronary angiography appropriately in men and women with chest pain? Eur Heart J 32 2011 1331 1336
7. E.L. Barrett-Connor, B.A. Cohn, and D.L. Wingard Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study JAMA 265 1991 627 631
8. C. Kreatsoulas, M.K. Natarajan, and R. Khatun Identifying women with severe angiographic coronary disease J Intern Med 268 2010 66 74
9. P.W. Wilson, R.B. D'Agostino, and D. Levy Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847
10. S.S. Bassuk, and J.E. Manson Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease J Appl Physiol 99 2005 1193 1204
11. P.D. Thompson, D. Buchner, and I.L. Pina Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity) Circulation 107 2003 3109 3116
12. K. Fox, M.A. Garcia, D. Ardissino Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG) Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology Eur Heart J 27 2006 1341 1381
13. R.J. Gibbons, J. Abrams, K. Chatterjee American College of Cardiology; American Heart Association Task Force on Practice Guidelines. Committee on the Management of Patients With Chronic Stable Angina ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 107 2003 149 158
14. T.D. Fraker Jr., S.D. Fihn, R.J. Gibbons American College of Cardiology; American Heart Association; American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group 2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 Guidelines for the management of patients with chronic stable angina Circulation 116 2007 2762 2772
15. M. Gulati, H.R. Black, and L.J. Shaw The prognostic value of a nomogram for exercise capacity in women N Engl J Med 353 2005 468 475
16. L.J. Shaw, E.D. Peterson, and L.K. Shaw Use of a prognostic treadmill score in identifying diagnostic coronary disease subgroups Circulation 98 1998 1622 1630
17. Y. Kwok, C. Kim, and D. Grady Meta-analysis of exercise testing to detect coronary artery disease in women Am J Cardiol 83 1999 660 666
18. L.J. Shaw, J.H. Mieres, R.H. Hendel WOMEN Trial Investigators Comparative effectiveness of exercise electrocardiography with or without myocardial perfusion single photon emission computed tomography in women with suspected coronary artery disease: results from the What Is the Optimal Method for Ischemia Evaluation in Women (WOMEN) trial Circulation 124 2011 1239 1249
19. J.H. Mieres, L.J. Shaw, A. Arai Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association Circulation 111 2005 682 696
20. L.J. Shaw, and A.E. Iskandrian Prognostic value of gated myocardial perfusion SPECT J Nucl Cardiol 11 2004 171 185
21. J.R. Panting, P.D. Gatehouse, and G.Z. Yang Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging N Engl J Med 346 2002 1948 1953
22. T.D. Karamitsos, J.R. Arnold, and T.J. Pegg Patients with syndrome X have normal transmural myocardial perfusion and oxygenation: a 3-T cardiovascular magnetic resonance imaging study Circ Cardiovasc Imaging 5 2012 194 200
23. M. Gulati, R.M. Cooper-DeHoff, and C. McClure Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project Arch Intern Med 169 2009 843 850
24. M.J. Budoff, J.G. Jollis, D. Dowe for the VCT Study Group Diagnostic accuracy of coronary artery calcium for obstructive disease: results from the ACCURACY trial Int J Cardiol 2011 [E-pub ahead of print]
25. M.J. Budoff, L.J. Shaw, and S.T. Liu Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients J Am Coll Cardiol 49 2007 1860 1870
26. R. Tota-Maharaj, M.J. Blaha, and J.W. McEvoy Coronary artery calcium for the prediction of mortality in young adults <45 years old and elderly adults >75 years old Eur Heart J 33 2012 2955 2962
27. L. Husak, V. Vaccarino, and E. Veledar Comparison of angiographic findings among postmenopausal women using unopposed estrogen, estrogen/progestin combinations, and nonusers Am J Cardiol 93 2004 563 568
28. C.N. Merz, M.B. Olson, and C. McClure A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: results from the National Institutes of Health/National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) Am Heart J 159 2010 987.e1 987.e7
29. M. Gerhard, and P. Ganz How do we explain the clinical benefits of estrogen? From bedside to bench Circulation 92 1995 5 8
30. M.E. Mendelsohn, and R.H. Karas The protective effects of estrogen on the cardiovascular system N Engl J Med 340 1999 1801 1811
31. D.M. Herrington, D.M. Reboussin, and K.B. Brosnihan Effects of estrogen replacement on the progression of coronary-artery atherosclerosis N Engl J Med 343 2000 522 529
32. C.N. Merz, B.D. Johnson, and S.L. Berga Women's Ischemia Syndrome Evaluation Study Group. Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) J Womens Health (Larchmt) 18 2009 1315 1322
33. J.E. Rossouw, R.L. Prentice, and J.E. Manson Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause JAMA 297 2007 1465 1477
34. J.E. Rossouw, G.L. Anderson, and R.L. Prentice Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
35. F. Grodstein, J.E. Manson, and M.J. Stampfer Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation J Womens Health (Larchmt) 15 2006 35 44
36. B. Zegura, B. Guzic-Salobir, and M. Sebestjen The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women Menopause 13 2006 643 650
37. V.A. Moyer on behalf of the U.S. Preventive Services Task Force Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions: U.S. Preventive Services Task Force Recommendation Statement Ann Intern Med 158 2013 47 54
38. R. Sicari, A. Palinkas, and E.G. Pasanisi Long-term survival of patients with chest pain syndrome and angiographically normal or near-normal coronary arteries: the additional prognostic value of dipyridamole echocardiography test (DET) Eur Heart J 26 2005 2136 2141
39. R. Bugiardini, O. Manfrini, and C. Pizzi Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms Circulation 109 2004 2518 2523
40. M.R. Patel, E.D. Peterson, and D. Dai Low diagnostic yield of elective coronary angiography N Engl J Med 362 2010 886 895
41. V. Vaccarino, L. Parsons, and N.R. Every Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants N Engl J Med 341 1999 217 225
42. L. Cho, B. Hoogwerf, and J. Huang Gender differences in utilization of effective cardiovascular secondary prevention: a Cleveland clinic prevention database study J Womens Health (Larchmt) 17 2008 515 521
43. A.L. Blomkalns, A.Y. Chen, J.S. Hochman CRUSADE Investigators Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative J Am Coll Cardiol 45 2005 832 837
44. R. Sarbaziha, T. Sedlak, and C. Shufelt Therapy for stable angina in women P T 37 2012 400 404
45. D.A. Morrow, B.M. Scirica, and E. Karwatowska-Prokopczuk Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial JAMA 297 2007 1775 1783
46. P.H. Stone, B.R. Chaitman, and K. Stocke The anti-ischemic mechanism of action of ranolazine in stable ischemic heart disease J Am Coll Cardiol 56 2010 934 942
47. J.S. Berger, M.C. Roncaglioni, and F. Avanzini Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials JAMA 295 2006 306 313
48. M. O'Donoghue, W.E. Boden, and E. Braunwald Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis JAMA 300 2008 71 80
49. L.J. Shaw, C.N. Merz, C.J. Pepine Women's Ischemia Syndrome Evaluation (WISE) Investigators The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation Circulation 114 2006 894 904